Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions
Biodesix, Inc. (NASDAQ:BDSX) is one of the best oversold growth stocks to invest in now. Canaccord lifted the price target on Biodesix, Inc.
Biodesix Inc (BDSX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 686,021 | $20,464,007 | +2% | 2.06% |
| 2. | Birchview Capital Matthew Strobeck | 286,804 | $8,555,362 | 4.94% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 185,691 | $5,539,163 | +60% | 0% |
| 4. | Walleye Capital Will England | 124,803 | $3,722,873 | +68% | 0% |
| 5. | Renaissance Technologies Jim Simons | 32,348 | $964,941 | +13% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.02 | 100,000 | $1,001,990.00 | 655,810 | 2026-11-10 | Filing | |
| $24.47 | 15,000 | $366,991.50 | 555,810 | 2026-08-12 | Filing | |
| $24.01 | 13,700 | $328,910.97 | 540,810 | 2026-08-11 | Filing | |
| $24.25 | 13,900 | $337,029.13 | 527,110 | 2026-08-10 | Filing | |
| $11.80 | 20,000 | $236,064.00 | 1,563,210 | 2026-01-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.78 | 556 | $7,103.23 | 10,359 | 2026-02-23 | Filing | |
| $12.78 | 535 | $6,834.95 | 9,819 | 2026-02-23 | Filing | |
| $12.78 | 535 | $6,834.95 | 16,231 | 2026-02-23 | Filing | |
| $12.78 | 211 | $2,695.65 | 1,586 | 2026-02-23 | Filing | |
| $12.78 | 1,490 | $19,035.64 | 48,767 | 2026-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 539,824 | $16,102,950 | 1.15% | |
| 2. | 287,615 | $8,579,555 | 0.01% | |
| 3. | 284,169 | $8,476,761 | 0% | |
| 4. | 234,542 | $6,996,388 | 1.04% | |
| 5. | 72,621 | $2,166,284 | 0.2% |
News See All
10 Oversold Growth Stocks to Invest In Now
In this article, we will look at the 10 Oversold Growth Stocks to Invest In Now.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript May 4, 2026Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.81, expectations were $-1.12983.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2025 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX) Q4 2025 Earnings Call Transcript February 26, 2026Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.49, expectations were $-1.05.
Biodesix, Inc. (NASDAQ:BDSX) Q3 2025 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX) Q3 2025 Earnings Call Transcript November 3, 2025Biodesix, Inc. beats earnings expectations. Reported EPS is $-1.16, expectations were $-1.6.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript August 9, 2025 Operator: Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call.
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers
Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new partnership with the Association of Pulmonary Advanced Practice Providers/APAPP.
12 Best Penny Stocks Under $1 to Buy Now
On July 18, Greg Tuorto of Goldman Sachs joined CNBC's 'Closing Bell' to state that the small-cap market is starting to show signs of life.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript May 13, 2025Biodesix, Inc. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript March 3, 2025Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.07.
Hedge Fund Resource Center